Johnson & Johnson to Pay $8B to Man Claiming His Breast Tissue Became Enlarged After Taking Drug

Johnson & Johnson to Pay $8B to Man Claiming His Breast Tissue Became Enlarged After Taking Drug
The Johnson and Johnson logo is seen at an office building in Singapore, on Jan. 17, 2018. Reuters/Thomas White
Jack Phillips
Jack Phillips
Breaking News Reporter
|Updated:

Johnson & Johnson, the pharmaceutical giant, has to pay $8 billion to a man who developed an unwanted side effect from taking Risperdal, an anti-psychotic drug.

The man, 26-year-old Nicholas Murray, claimed that the firm failed to warn him about the side effects. He claimed he developed breasts via an incurable condition known as gynecomastia after taking the medication, CBS News reported.
Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics